Background: Elevated 1 hour plasma glucose (>155mg/dl) and glucose curve shape are predictive markers of diabetes risk. We evaluated varying patterns of impaired glucose tolerance and associated CVD risk.

Methods: At Stanford’s South Asian Translational Heart Initiative, 260 patients were evaluated for diabetic and CVD risk: OGTT with insulin, lipid panel, HbA1c, blood pressure, BMI, QRisk2 (10-year CVD risk), inflammatory markers, and FHx. Glucose curve “shape” was categorized by phase changes and time of curve peak.

Results: Classification showed 78.3% of patients were prediabetic and 5.2% had normal glucose tolerance (NGT) but elevated 1 hour glucose. These subgroups also exhibited more unclassified and monophasic 60 min glucose peak (Mono60) shapes compared to the total population (83.8% vs. 51.9%, p <0.01). Mono 60 patients had significantly higher fasting and 2 hour glucose, insulin levels, and QRisk2 (16% vs. 12%, p<0.01) than Mono30. The median CRP of Mono60 was higher than Mono 30 (1 vs. 1.5, p=0.02). A “dose-dependent” relationship between prediabetic criteria and average glucose area under curve (AUC) was observed; elevated 1 hour glucose further stratified prediabetic severity (Figure 1).

Conclusion: Mono60 glucose patterns exceed the CVD risk stratification of prediabetes alone and may indicate a need for more aggressive medical therapy to prevent diabetes and CVD progression.


J.L. Shearer: None. K. Josan: None. A. Khandelwal: None. S. Nallamshetty: None. F. Abbasi: None. R. Dash: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at